These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8208398)

  • 1. Parkinsonism caused by petroleum waste ingestion.
    Tetrud JW; Langston JW; Irwin I; Snow B
    Neurology; 1994 Jun; 44(6):1051-4. PubMed ID: 8208398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism.
    Snow BJ; Vingerhoets FJ; Langston JW; Tetrud JW; Sossi V; Calne DB
    J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):313-6. PubMed ID: 10675212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.
    Vingerhoets FJ; Snow BJ; Tetrud JW; Langston JW; Schulzer M; Calne DB
    Ann Neurol; 1994 Nov; 36(5):765-70. PubMed ID: 7979223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonism secondary to petroleum exposure.
    McCrank E
    Neurology; 1995 Nov; 45(11):2112. PubMed ID: 7501171
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination and visualization of damage to striatal dopaminergic terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism by [18F]-labeled 6-fluoro-L-dopa and positron emission tomography.
    Chiueh CC; Firnau G; Burns RS; Nahmias C; Chirakal R; Kopin IJ; Garnett ES
    Adv Neurol; 1987; 45():167-9. PubMed ID: 3103385
    [No Abstract]   [Full Text] [Related]  

  • 6. Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys.
    Hayase N; Tomiyoshi K; Watanabe K; Horikoshi S; Shibasaki T; Ohye C
    Ann Nucl Med; 1995 Aug; 9(3):119-23. PubMed ID: 8534583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Widner H; Tetrud J; Rehncrona S; Snow B; Brundin P; Gustavii B; Björklund A; Lindvall O; Langston JW
    N Engl J Med; 1992 Nov; 327(22):1556-63. PubMed ID: 1435882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.
    Doudet DJ; Chan GL; Holden JE; McGeer EG; Aigner TA; Wyatt RJ; Ruth TJ
    Synapse; 1998 Jul; 29(3):225-32. PubMed ID: 9635892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive change following MPTP exposure.
    Stern Y; Tetrud JW; Martin WR; Kutner SJ; Langston JW
    Neurology; 1990 Feb; 40(2):261-4. PubMed ID: 2300245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of adenosine increase in the striatum in common marmoset parkinsonism induced by MPTP.
    Nomoto M; Shimizu T; Iwata S; Kaseda S; Fukuda T
    Adv Neurol; 1999; 80():125-8. PubMed ID: 10410711
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Burns RS; LeWitt PA; Ebert MH; Pakkenberg H; Kopin IJ
    N Engl J Med; 1985 May; 312(22):1418-21. PubMed ID: 2581135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys.
    Guttman M; Yong VW; Kim SU; Calne DB; Martin WR; Adam MJ; Ruth TJ
    Synapse; 1988; 2(5):469-73. PubMed ID: 3263709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice.
    Mizukawa K; Ogawa N; Sora YH
    Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):121-8. PubMed ID: 3258432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of acidic fibroblast growth factor on experimental parkinsonism and levels of dopamine and its metabolites in the striatum of mice of various ages].
    Kucherianu VG; Kryzhanovskiĭ GN; Kudrin VS; Iurasov VV; Nikushkin EV; Zhigal'tsev IV
    Biull Eksp Biol Med; 1999 May; 127(5):502-5. PubMed ID: 10399565
    [No Abstract]   [Full Text] [Related]  

  • 15. n-Hexane-induced parkinsonism: pathogenetic hypotheses.
    Pezzoli G; Antonini A; Barbieri S; Canesi M; Perbellini L; Zecchinelli A; Mariani CB; Bonetti A; Leenders KL
    Mov Disord; 1995 May; 10(3):279-82. PubMed ID: 7651443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by MPTP.
    Eldridge R; Rocca WA
    N Engl J Med; 1985 Oct; 313(18):1159-60. PubMed ID: 3876508
    [No Abstract]   [Full Text] [Related]  

  • 17. [Parkinsonism and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (review of the literature)].
    Atadzhanov MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(4):117-21. PubMed ID: 1650080
    [No Abstract]   [Full Text] [Related]  

  • 18. [Presynaptic nigrostriatal function in Parkinson disease and Parkinson-plus syndromes. Comparative studies using positron emission tomography with L-6-(18F)fluorodopa].
    Cordes M; Poewe W
    Nervenarzt; 1994 Oct; 65(10):696-9. PubMed ID: 7808568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism.
    Schneider JS; DiStefano L
    Neurology; 1994 Apr; 44(4):748-50. PubMed ID: 8164837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.